Madrigal Pharmaceuticals Inc (MDGL)
NASDAQ
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -48.239 | -26.682 | -9.682 | -18.102 | -55.481 | -86.323 | -92.891 | -74.494 |
Return on Equity (%) | -60.79 | -28.494 | -9.954 | -18.79 | -61.61 | -110.919 | -150.116 | -123.981 |
Return on Invested Capital (%) | -58.106 | -29.325 | -12.342 | -21.257 | -62.959 | -111.211 | -132.602 | -99.153 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 3.046 | 11.253 | 27.446 | 23.942 | 13.73 | 10.282 | 9.834 | 18.668 |
Earnings Per Share | -2.208 | -1.923 | -1.888 | -4.825 | -11.571 | -12.68 | -14.714 | -17.208 |
Cash Per Share | 1.602 | 9.176 | 3.302 | 2.684 | 3.09 | 1.902 | 16.517 | 4.602 |
Working Capital Per Share | 3.046 | 11.234 | 27.433 | 23.856 | 13.652 | 10.216 | 12.229 | 23.89 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -2.208 | -1.923 | -1.888 | -4.825 | -11.571 | -12.68 | -14.714 | -17.208 |
EBITDA Per Share | -2.208 | -1.923 | -1.888 | -4.825 | -11.571 | -12.68 | -14.714 | -17.208 |
Free Cash Flow Per Share | -2.208 | -1.92 | -1.892 | -4.821 | -11.579 | -12.69 | -14.726 | -17.164 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 11.95M | 14.23M | 15.41M | 15.43M | 15.51M | 17.1M | 18.1M | N/A |
Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | 18.1M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 6.78B |
Price to Earnings Ratio | -18.12 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 67.77 |
Price to Book Ratio | 16.7 |
Dividend Yield | - |
Shares Outstanding | 21.81M |
Average Volume (1 week) | 450.97k |
Average Volume (1 Month) | 335.79k |
52 Week Change | 32.79% |
52 Week High | 368.29 |
52 Week Low | 168.2462 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.